Phenylketonuria (PKU) Treatment Market Size

Phenylketonuria Treatment Market Size

Phenylketonuria Treatment Market size was valued at USD 737.7 million in 2023 and is estimated to grow at a CAGR of 7.2% from 2024 to 2032. The increasing demand for PKU treatment is driven by several factors including the rising incidence of PKU globally and advancements in treatment options.

To get key market trends

  Download Free Sample

Enhanced newborn screening programs are leading to earlier detection and diagnosis, which boosts the demand for effective management therapies. Also, ongoing research and development are yielding new therapeutic solutions such as gene therapy and novel drug formulations which tend to improve patient outcomes. For instance, in November 2023, new research from the Perelman School of Medicine at the University of Pennsylvania explores potential future treatments using advanced CRISPR gene editing techniques, specifically prime and base editing. These advancements expect to pave the way for innovative therapies in genetic medicine. Furthermore, increased awareness among healthcare providers and patients about the benefits of early and continuous treatment contributes to the growing market demand for PKU treatments.
 

PKU treatment refers to medical interventions and therapies aimed at managing and mitigating the effects of PKU, a genetic disorder characterized by the body's inability to metabolize the amino acid phenylalanine. The primary goal of PKU treatment is to reduce phenylalanine levels in the blood to prevent neurological damage and other complications.